CRISPRi chemical genetics and comparative genomics identify genes mediating drug potency in Mycobacterium tuberculosis

Mycobacterium tuberculosis (Mtb) infection is notoriously difficult to treat. Treatment efficacy is limited by Mtb’s intrinsic drug resistance, as well as its ability to evolve acquired resistance to all antituberculars in clinical use. A deeper understanding of the bacterial pathways that influence...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Shuqi, Poulton, Nicholas C., Chang, Jesseon S., Azadian, Zachary A., DeJesus, Michael A., Ruecker, Nadine, Zimmerman, Matthew D., Eckartt, Kathryn A., Bosch, Barbara, Engelhart, Curtis A., Sullivan, Daniel F., Gengenbacher, Martin, Dartois, Véronique A., Schnappinger, Dirk, Rock, Jeremy M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159947/
https://www.ncbi.nlm.nih.gov/pubmed/35637331
http://dx.doi.org/10.1038/s41564-022-01130-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159947/
https://www.ncbi.nlm.nih.gov/pubmed/35637331
http://dx.doi.org/10.1038/s41564-022-01130-y

Ejemplares similares